头脑风暴

Indian Firms Signed Contracts To Receive Export Payments From Russia in Yuan: Pharma CEO_我的网站

A |     Sputnik spoke with Dr. D. B. Bhaaskara, CEO of the multinational company Roerich Healthcare, about the current state of pharma trade with Russia.,Sputnik: Can you explain the current state of pharma supplies to Russia?,D. B. Bhaaskara: Currently, pharmaceutical shipments of Indian firms to Russia are at the same level even after the sanctions. But, there are many proposals (supplies) that Russians are not getting from the European Union. Russians are looking for these materials (chemicals, excipients, APIs [Active Pharmaceutical Ingredients]) with several Indian manufacturers. They have to develop links with Indian firms. There are many proposals from Russia - these proposals are under consideration from the Indian side.,Sputnik: There were reports of delayed payments from Russia initially after sanctions. As we see, trade has jumped manifold in the energy and fertilizer sectors. Do you think payment issues have been resolved in other sectors as well?,D. B. Bhaaskara: Several Indian companies have signed contracts in yuan, which means they are ready to receive payment in China's yuan. Still, the preferred mode of settlement is in the Indian rupee. As export procedures closed successfully in USD/euro/INR, Russians set aside yuan contracts.,My company is receiving regular payment without any delay in Indian rupees or USD or sometimes in euros.,Sputnik: What about logistical issues, as sanctions hit the shipping sector?,D. B. Bhaaskara: The logistical issues are still there because few airlines — namely Aeroflot, Emirates, Qatar, and Turkish — are available for transportation. Transportation costs are slightly high because of no regular cargo consignments. They vary between $8-12 per kg compared to $5 per kg in a normal situation.,Cargo sea shipment is still in a mess. The only port in Gujarat accepts Russian shipping. Here again, the container price is very, very high. We have to pay anything between $9,000 - 12,000 for a container. When there was no conflict or sanctions, it was $2,500 per container.,We have tried to send our shipments via Iran. So, from Gujarat port, the shipment reaches an Iranian port, and from there, it goes via road or rail to Moscow. But, it is taking a much longer time. In general, it is supposed to arrive in 30-40 days, but on an experimental basis, some companies sent their materials via the Iran route, [and they are] still on their way even after two months.,Shanghai is very crowded and has also been hit by the pandemic, making it unsuitable for us. So, the only problem right now is logistics; there is no payment issue.,Some Russian companies have an account with European banks operating in Russia dealing in oil and gas payments. Those banks are being used to send money anywhere worldwide, even with sanctions.,Sputnik: Western firms intended to withdraw their operations in Russia in response to Moscow's special military operation. Do you see some significant investments from Indian pharma companies in Russia to fill the vacuum created by the west?,D. B. Bhaaskara: There are long-pending proposals from a couple of governors, such as [in] Volgograd and Kazan, inviting India's major pharma companies to set up manufacturing units in their region. But, due to the pandemic, nothing moved ahead.,A delegation will be going to Russia to explore the opportunities in Russia in July. A few Indian companies, such as Sun Pharma and Advance Pharma, have manufacturing units in Russia doing finished formulations.,Hopefully, some new companies are interested in setting up units there now. But, Russia is looking to scale up raw material manufacturing, e.g., API. For this, much homework related to regulation should be done between the two governments, especially under sanctions.,Also, big companies such as Sun Pharma, Aurbindo, and Dr. Reddy, all with significant exposure to the US market, may try to avoid investing in Russia because they are scared of the risk associated with sanctions.,Medium-scale companies can come forward to set up raw material (API) manufacturing in Russia. However, it is unclear whether Indian workers/professionals can go and work in Russia. Setting up a new unit in unknown topography with a different language and culture is a little complicated. A lot of these questions are unanswered.。

B | 北京时间1月15日，在联邦贸易委员会（FTC）指控高通公司滥用其市场支配地位的情况下，高通公司与苹果之间的专利许可费纠纷被曝光。

C | 高通公司表示，该公司的技术对于iPhone的正常运行至关重要。

D | 但苹果认为，每部iPhone 7.50美元的许可费远远超过了高通公司本身的价值。

E | 据证词显示，2006年，时任苹果首席执行官的史蒂夫•乔布斯（Steve Jobs）并不反对向高通公司支付相当于每部iPhone 7.50美元的许可费。但苹果首席运营官杰夫•威廉姆斯（Jeff Williams）表示，在2012年协议到期时，许可费可能上涨，威胁到苹果的利润，并导致重新谈判。”“高通公司用枪指着我们的头，”他在联邦贸易委员会和高通反垄断案中对美国地区法官露西·科尔说。这听起来可能不算多，但我们每年销售数亿部手机，并支付数十亿美元的许可费。”这一许可费是联邦贸易委员会指控高通滥用其在全球智能手机市场的主导地位的关键。高通公司表示，其专利是所有现代高速移动数据网络的基础。授权费已成为高通公司的主要利润来源，使其能够为技术开发提供资金，并帮助高通公司成为业界领先的芯片制造商。FTC和高通公司的客户认为，高通公司的技术只是智能手机对消费者如此具有吸引力的一部分，但它通过向消费者收取过多的费用来欺负他们。高通公司反驳说，该公司的技术是手机的基础，手机的许可费相对较低。高通公司表示，它的技术决定了手机如何有效地访问高速数据，如果没有高速数据，iPhone只是一个昂贵的iPod。

F | 高通公司坚持继续向该行业的其他部门提供技术，其实践符合行业规范。与每部iPhone高达793美元的平均价格相比，7.50美元只是一个软膏。但考虑到iPhone的销量，苹果公司要支付累积的许可费。2015年，高通公司的授权收入达到79亿美元的峰值。在最近的一个财政年度，高通公司的授权部门赚了51.6亿美元，当苹果停止支付许可费时，就赚了。上一财年，苹果售出2.17亿部iPhone。

Current article:http://95f.shuicengchongmingnouhuawang.bond/dtwcl/le5.html

Published on:05:17:57